| Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders. | |
| | |
MedLine Citation:
|
PMID: 20673155 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Abstract Tumor necrosis factor alpha (TNF-α) plays an important role in host defense and possibly wound healing. It is also linked to the pathophysiology of many inflammatory diseases, including psoriasis. The TNF antagonists are a class of agents that have proven effective in treating psoriasis and psoriatic arthritis, yet the immunosuppressive effects of these agents raise concern over their use perioperatively. Currently, there is no consensus as to when TNF antagonists should be discontinued prior to surgery. Furthermore, data on the topic are limited to inflammatory bowel disease (IBD) and rheumatoid arthritis (RA). This paper reviews the literature on post-surgical outcomes in patients with RA and IBD receiving anti-TNF therapy. Although most studies reveal no statistically significant increased risk of post-surgical complications in these patients, the retrospective design and small sample size of these studies limits interpretation. Furthermore, when applying these data to psoriasis and psoriatic arthritis, physicians must also consider disease severity, individual comorbidities, and the pharmacokinetics of the different TNF antagonists. Additional studies are needed in psoriasis and psoriatic arthritis in order to develop truly evidence-based dermatologic guidelines for perioperative management of the TNF antagonists. |
| | |
Authors:
|
Meghan T Hession; Alice B Gottlieb |
Related Documents
:
|
14730625 - Systemic tumor necrosis factor alpha mediates an increase in peripheral cd11bhigh osteo... 1836185 - Therapy against murine collagen-induced arthritis with t cell receptor v beta-specific ... 2388205 - The effect of human interleukin 1 on proteoglycan metabolism in human and porcine carti... 15158185 - T-box transcription-factor-deficient mice display increased joint pathology and failure... 14688305 - Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in norma... 8220995 - Epinephrine reduces the severity of catheter-induced urethral inflammation by action at... |
Publication Detail:
|
Type: Journal Article Date: 2010-08-01 |
Journal Detail:
|
Title: The Journal of dermatological treatment Volume: 22 ISSN: 1471-1753 ISO Abbreviation: J Dermatolog Treat Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-03-07 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8918133 Medline TA: J Dermatolog Treat Country: England |
Other Details:
|
Languages: eng Pagination: 90-101 Citation Subset: IM |
Affiliation:
|
Tufts Medical Center, Boston, MA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin.
Next Document: The weight of a finger-tip unit of ointment in 5-gram tubes.